Citation | Sperandio, D; Aktoudianakis, V; Babaoglu, K; Chen, X; Elbel, K; Chin, G; Corkey, B; Du, J; Jiang, B; Kobayashi, T; Mackman, R; Martinez, R; Yang, H; Zablocki, J; Kusam, S; Jordan, K; Webb, H; Bates, JG; Lad, L; Mish, M; Niedziela-Majka, A; Metobo, S; Sapre, A; Hung, M; Jin, D; Fung, W; Kan, E; Eisenberg, G; Larson, N; Newby, ZER; Lansdon, E; Tay, C; Neve, RM; Shevick, SL; Breckenridge, DG Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg Med Chem27:457-469 (2019) [PubMed] Article |
---|
SMILES | Cc1noc(C)c1-c1cc(-c2c(C)[nH]nc2-c2ccccc2)c2nc([nH]c2c1)C1CC1 |(55.81,-36.75,;54.34,-36.28,;53.86,-34.82,;52.32,-34.82,;51.85,-36.29,;50.39,-36.77,;53.11,-37.19,;53.11,-38.73,;54.45,-39.49,;54.45,-41.04,;55.79,-41.81,;57.2,-41.18,;57.52,-39.67,;58.24,-42.33,;57.46,-43.66,;55.95,-43.34,;54.81,-44.37,;53.35,-43.89,;52.21,-44.93,;52.53,-46.43,;54.01,-46.9,;55.14,-45.87,;53.11,-41.81,;52.8,-43.32,;51.27,-43.48,;50.64,-42.08,;51.78,-41.05,;51.78,-39.5,;50.5,-44.82,;49.18,-45.59,;50.51,-46.36,)| |